Financials
- Market Capitalization 284.55 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.14
売上高対価格比率
26.03
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3288 | EYPT EyePoint, Inc. - Common Stock | 3.34 USD | -1.76% | +5.36% | -22.14% | -72.17% | 287.95 M USD | ||
| 3298 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.74 USD | -0.80% | +0.81% | -2.09% | -58.63% | 285.35 M USD | ||
| 3305 | SRZN Surrozen, Inc. - Common Stock | 24.09 USD | -18.86% | -14.33% | +26.59% | +72.32% | 283.14 M USD | ||
| 3312 | ABEO Abeona Therapeutics Inc. - Common Stock | 4.93 USD | -0.20% | -3.71% | -8.87% | -9.21% | 281.92 M USD |